Key Takeaways From CryoPort Analyst Ratings
Portfolio Pulse from Benzinga Insights
CryoPort (NASDAQ:CYRX) has received mixed analyst ratings over the past quarter, with a notable decrease in average price targets. Analysts have lowered their ratings and price targets, reflecting concerns over the company's recent performance, including a 13.09% decline in revenue growth. Despite challenges in debt management, CryoPort maintains strong net margins and returns on equity and assets.
August 07, 2024 | 7:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CryoPort has received mixed analyst ratings, with a significant decrease in average price targets from $18.50 to $10.25. Analysts have lowered their ratings and price targets, reflecting concerns over the company's recent performance, including a 13.09% decline in revenue growth. Despite challenges in debt management, CryoPort maintains strong net margins and returns on equity and assets.
The significant decrease in average price targets and the lowering of ratings by multiple analysts indicate a bearish outlook for CryoPort in the short term. The company's recent revenue decline and challenges in debt management further support this negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100